Literature DB >> 24034022

Resistive index and MELD-Na: nephrologic monitoring in cirrhotic patients awaiting liver transplantation.

I Umbro1, F Tinti, F Fiacco, A Zavatto, P Piselli, V Di Natale, S Lai, A Vitarelli, S Ginanni Corradini, M Rossi, L Poli, P B Berloco, A P Mitterhofer.   

Abstract

Renal dysfunction in cirrhotic patients is primarily related to disturbances in circulatory function. In decompensated cirrhosis, ascites and water retention are associated with development of dilutional hyponatremia. The arterial resistive index (RI) is a measure of resistance to arterial flow within the renal vascular bed. Hyponatremia is an independent predictor of mortality in patients with ascites. The aim of this study was to evaluate intrarenal RI in end-stage liver disease (ESLD) patients awaiting liver transplantation (LT) and its association with renal and hepatic function as assessed by Model for End-Stage Liver Disease (MELD) and MELD-Na scores. We evaluated 40 cirrhotic patients (23 males, 17 females) awaiting LT from January 2009 to January 2012. Twenty-six of the 40 patients (65%) showed a renal RI ≥ 0.70, the normal value according to standard reported evaluations. Patients with RI ≥ 0.70 showed significantly higher MELD and MELD-Na scores as well as greater higher serum creatinine and lower serum sodium concentrations compared with subject displaying RI <0.70. The most relevant result of our study was the strong association between elevated renal RI in ESLD patients and advanced liver dysfunction, as demonstrated by MELD and MELD-Na scores, hyponatremia, ascites, and acute renal failure episodes. In conclusion, this study suggested that intrarenal RI assessment should be considered in the clinical and nephrologic monitoring of cirrhotic patients awaiting LT.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24034022     DOI: 10.1016/j.transproceed.2013.07.040

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

Review 1.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

2.  The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.

Authors:  Georg P Györi; David Pereyra; Benedikt Rumpf; Hubert Hackl; Christoph Köditz; Gregor Ortmayr; Thomas Reiberger; Michael Trauner; Gabriela A Berlakovich; Patrick Starlinger
Journal:  Hepatology       Date:  2020-04-23       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.